Medications
This
page
is
part
of
the
FHIR
Specification
(v4.3.0:
R4B
(v5.0.0-draft-final:
Final
QA
Preview
for
R5
-
STU
see
ballot
notes
).
The
current
version
which
supercedes
this
version
is
5.0.0
.
For
a
full
list
of
available
versions,
see
the
Directory
of
published
versions
.
Page
versions:
R5
R4B
R4
R3
| Pharmacy Work Group | Maturity Level : N/A | Standards Status : Informative |
Compartments
:
|
Raw XML ( canonical form + also see XML Format Specification )
Intravenous Chemotherapy (Inpatient order) - Alemtuzumab - completed (id = "medadmin0304")
<?xml version="1.0" encoding="UTF-8"?> <MedicationAdministration xmlns="http://hl7.org/fhir"> <id value="medadmin0304"/>display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk<text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"><p> <b> Generated Narrative: MedicationAdministration</b> <a name="medadmin0304"> </a> </p> <div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource MedicationAdministration "medadmin0304" </p> </div> <p> <b> status</b> : completed</p> <h3> Medications</h3> <table class="grid"><tr> <td> -</td> <td> <b> Reference</b> </td> </tr> <tr> <td> *</td> <td> <a name="med0303"> </a> <blockquote> <p/> <p> <a name="med0303"> </a> </p> <p> <b> code</b> : Alemtuzumab 10mg/ml (Lemtrada) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/4.0.0/CodeSystem-v3-rxNorm.html">RxNorm</a> #1594660)</span> </p> </blockquote> </td> </tr> </table> <p> <b> subject</b> : <a href="patient-example-a.html">Patient/pat1: Donald Duck</a> "Donald DUCK"</p> <p> <b> encounter</b> : <a href="encounter-example-f001-heart.html">Encounter/f001: encounter who leads to this prescription</a> </p> <p> <b> occurence</b> : 2015-01-15T04:30:00+01:00 --> 2015-01-15T14:30:00+01:00</p> <blockquote> <p> <b> performer</b> </p> <h3> Actors</h3> <table class="grid"><tr> <td> -</td> <td> <b> Reference</b> </td> </tr> <tr> <td> *</td> <td> <a href="practitioner-example-f007-sh.html">Practitioner/f007: Patrick Pump</a> "Simone HEPS"</td> </tr> </table> </blockquote> <h3> Reasons</h3> <table class="grid"><tr> <td> -</td> <td> <b> Reference</b> </td> </tr> <tr> <td> *</td> <td> <a href="condition-example-f202-malignancy.html">Condition/f202</a> </td> </tr> </table> <p> <b> request</b> : <a href="medicationrequest0319.html">MedicationRequest/medrx0319</a> </p> <h3> Dosages</h3> <table class="grid"><tr> <td> -</td> <td> <b> Text</b> </td> <td> <b> Route</b> </td> <td> <b> Method</b> </td> <td> <b> Dose</b> </td> </tr> <tr> <td> *</td> <td> Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk</td> <td> Intravenous route (qualifier value) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a> #47625008)</span> </td> <td> Inject - dosing instruction imperative (qualifier value) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a> #422145002)</span> </td> <td> 3 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM code mg = 'mg')</span> </td> </tr> </table> </div> </text> <contained> <Medication> <id value="med0303"/> <code> <coding> <system value="http://www.nlm.nih.gov/research/umls/rxnorm"/> <code value="1594660"/> <display value="Alemtuzumab 10mg/ml (Lemtrada)"/> </coding> </code> </Medication> </contained> <status value="completed"/><medication> <reference> <reference value="#med0303"/> </reference> </medication> <subject> <reference value="Patient/pat1"/> <display value="Donald Duck"/> </subject><encounter> <reference value="Encounter/f001"/> <display value="encounter who leads to this prescription"/> </encounter> <occurencePeriod> <start value="2015-01-15T04:30:00+01:00"/> <end value="2015-01-15T14:30:00+01:00"/> </occurencePeriod> <performer> <actor><reference> <reference value="Practitioner/f007"/> <display value="Patrick Pump"/> </reference> </actor> </performer><reason> <reference> <reference value="Condition/f202"/> </reference> </reason> <request> <reference value="MedicationRequest/medrx0319"/> </request> <dosage>Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk<text value="Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk"/> <route> <coding> <system value="http://snomed.info/sct"/> <code value="47625008"/> <display value="Intravenous route (qualifier value)"/> </coding> </route> <method> <coding> <system value="http://snomed.info/sct"/> <code value="422145002"/> <display value="Inject - dosing instruction imperative (qualifier value)"/> </coding> </method> <dose> <value value="3"/> <unit value="mg"/> <system value="http://unitsofmeasure.org"/> <code value="mg"/> </dose> </dosage> </ MedicationAdministration >
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.
FHIR
®©
HL7.org
2011+.
FHIR
Release
4B
(v4.3.0)
hl7.fhir.r4b.core#4.3.0
R5
hl7.fhir.core#5.0.0-draft-final
generated
on
Sat,
May
28,
2022
12:56+1000.
Wed,
Mar
1,
2023
23:06+1100.
Links:
Search
|
Version
History
|
Table
of
Contents
|
Glossary
|
QA
Page
|
Compare
to
R4
R4B
|
Compare
to
R5
Draft
|
|
Propose
a
change